MAPT and schizophrenia: It has been linked to brain diseases such as schizophrenia and vascular dementia (Romay et al., 2019; Ruso-Julve et al., 2019) and was predictive of both tau and amyloid pathology in our previous analysis of the ROSMAP data (Tsatsanis et al., 2021).